| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.27 | 0.0007 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.2 | 0.001 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.2 | 0.002 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |